XCUR

Exicure, Inc. - Common Stock (XCUR)

About Exicure, Inc. - Common Stock (XCUR)

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.

Details

Daily high

$7.46

Daily low

$6.74

Price at open

$7.27

52 Week High

$36.00

52 Week Low

$1.44

Market cap

45.9M

Dividend yield

0.00%

Volume

18,898

Avg. volume

281,290

P/E ratio

-4.47

Exicure, Inc. - Common Stock News